Dassault Systemes and Inserm link up with aim of deciphering disease complexity

Published: 29-Mar-2016
Research & Development Digital

The agreement will draw from the expertise of each organisation to offer new perspectives for addressing scientific and health challenges


Dassault Systemes, a French specialist in 3D design software, 3D Digital Mock Up and Product Lifecycle Management (PLM) solutions, has signed an agreement with the French National Institute of Health and Medical Research (Inserm), to accelerate clinical research programmes using a virtual collaborative platform. The agreement will draw from the expertise of each organisation to offer new perspectives for addressing scientific and health challenges.

Inserm will use Dassault Systèmes’ 3DEXPERIENCE technology to conduct its biomedical research programmes in the areas of ageing, cancer, genomics and microbiota. The platform provides Inserm with an integrated virtual environment for open collaborative research, unified laboratory management and biological and chemical modelling and simulation from Dassault Systèmes’ BIOVIA flagship brand.

In turn, Dassault Systèmes will leverage big data from Inserm’s research programmes to calibrate and validate scientific models that can be applied to future technologies for clinical research. These models will enable the company to develop next-generation industry solutions targeting clinical trials, to accelerate decision-making and to enable earlier efficacy and safety demonstration with virtual trials.

'We seek out technologies that further our mission to observe and understand mechanisms of the living body and ultimately transfer this knowledge to therapeutic solutions for new and mutating diseases that are affecting the world’s growing population,' said Professor Yves Lévy, Chairman and CEO, Inserm. 'We lead long-term, competitive scientific programmes in human health and medicine and the Dassault Systèmes’ 3DEXPERIENCE platform will help us support collaboration, project management, data, resources, traceability and other processes.'

Bernard Charlès, President & CEO, Dassault Systèmes, said: 'This fusion of advanced clinical research and the virtual world is a stepping stone to the future of precision medicine and brings us closer to harmonising product, nature and life.'

  • Companies:
  • Dassault Systems
See more

You may also like

Manufacturing

What is MES and why should manufacturers invest in it?

Read more
A manufacturing execution system, often referred to as MES, has quickly become a staple within many businesses around the globe. Offering manufacturers a dynamic software solution that is capable of monitoring, tracking, controlling and documenting manufactured products throughout production, MES provides key decision makers with all of the information they require to implement efficiency driven changes to their operations

Trending Articles

  1. Fujifilm Diosynth Biotechnologies expands its biologic manufacturing capabilities at Hillerød site The CDMO's first expansion phase introduces six more 20,000 L bioreactors and two downstream processing streams to the facility
  2. Strategic partnership announced to develop ATMPs CCRM Nordic, Sahlgrenska Academy, and Sahlgrenska University Hospital are forming a strategic partnership relating to advanced therapy medicinal products (ATMPs)
  3. Lonza's Synaffix and BigHat Biosciences team up to develop ADC pipeline programme Synaffix's clinical-stage ADC platform technology will allow BigHat to expand and progress its ADC pipeline for oncological indications
  4. Picking a CDMO as a CGT developer: what to consider and why Cell and gene therapy development and manufacture can be risky and highly complex, so biopharma companies would benefit from investing in a reliable and experienced CDMO
  5. Neogap Therapeutics and NorthX Biologics team up to scale novel cancer cell therapy CDMO NorthX Biologics will work with Neogap to determine advanced manufacturing protocols for Neogap's personalised cancer cell therapy

Upcoming event

CPhI India

26–28 November 2024 | Online Conference & Networking | Delhi, India See all

You may also like

Manufacturing

What is MES and why should manufacturers invest in it?

A manufacturing execution system, often referred to as MES, has quickly become a staple within many businesses around the globe. Offering manufacturers a dynamic software solution that is capable of monitoring, tracking, controlling and documenting manufactured products throughout production, MES provides key decision makers with all of the information they require to implement efficiency driven changes to their operations
Research & Development

Ipsen to use Dassault Systemes' software to support drug discovery

Selects the Designed to Cure platform, which offers data integration, modelling and simulation capabilities
Digital

Dassault Systemes launches software solutions for the life sciences

Aims to digitally transform the complex processes behind the design, development and production of new drugs
Hi Tech Manufacturing

Dassault Systemes and Accelrys to merge

Accelrys launches information management and collaboration workspace called ScienceCloud
Research & Development

INTEGRA Bioscience's pipettes for streamlined and accurate liquid handling

Bioanalytical consultancy company BioApp solutions is currently using INTEGRA's pipettes to improve its pipetting consistency, and — therefore — the reproducibility of its results
Drug Delivery

PacBio launches Vega system, a compact long-read sequencing platform

New benchtop sequencer brings HiFi technology to researchers at $169,000
Manufacturing

iotaSciences launches new single-cell cloning platform XT to increase throughput and speed

The platform includes novel AI-powered single-cell verification and monoclonality reporting for gene therapy
Subscribe now